Correction: Genome-wide association study and trans-ethnic meta-analysis identify novel susceptibility loci for type 2 diabetes mellitus.

Autor: Elashi AA; College of Health and Life Sciences (CHLS), Foundation (QF), Hamad Bin Khalifa University (HBKU), Education City, DohaP.O. Box 34110, Qatar., Toor SM; College of Health and Life Sciences (CHLS), Foundation (QF), Hamad Bin Khalifa University (HBKU), Education City, DohaP.O. Box 34110, Qatar., Umlai UI; College of Health and Life Sciences (CHLS), Foundation (QF), Hamad Bin Khalifa University (HBKU), Education City, DohaP.O. Box 34110, Qatar., Al-Sarraj YA; Qatar Genome Program (QGP), Qatar Foundation Research, Development and Innovation, Qatar Foundation (QF), DohaP.O. Box 5825, Qatar., Taheri S; Qatar Metabolic Institute, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar., Suhre K; Bioinformatics Core, Weill Cornell Medicine-Qatar, Education City, DohaP.O. Box 24144, Qatar.; Department of Biophysics and Physiology, Weill Cornell Medicine, New York, 510065, USA., Abou-Samra AB; Qatar Metabolic Institute, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar., Albagha OME; College of Health and Life Sciences (CHLS), Foundation (QF), Hamad Bin Khalifa University (HBKU), Education City, DohaP.O. Box 34110, Qatar. oalbagha@hbku.edu.qa.; Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK. oalbagha@hbku.edu.qa.

Publikováno v: BMC medical genomics [BMC Med Genomics] 2024 May 16; Vol. 17 (1), pp. 131. Date of Electronic Publication: 2024 May 16.

The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR).

Autor: Inchakalody VP; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar., Hydrose SP; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar., Krishnankutty R; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Merhi M; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar., Therachiyil L; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar; College of Pharmacy, Qatar University, Doha, Qatar., Sasidharan Nair V; Department of Experimental Immunology, Helmholtz Centre for Infection Research, Germany., Elashi AA; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar., Khan AQ; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar., Taleb S; Genomics and Precision Medicine, Hamad Bin Khalifa University, Doha, Qatar., Raza A; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar., Yoosuf ZSKM; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar., Fernandes Q; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar; College of Medicine, Qatar University, Doha, Qatar., Al-Zaidan L; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar., Mestiri S; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar., Taib N; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar., Bedhiafi T; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar., Moustafa D; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar., Assami L; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar., Maalej KM; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar., Elkord E; Natural and Medical Sciences Research Center, University of Nizwa, Oman; Biomedical Research Center, School of Science, Engineering and Environment, University of Salford, Manchester, UK., Uddin S; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar; Translational Research Institute and Dermatology Institute, Academic Health System, Doha, Qatar., Al Homsi U; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar., Dermime S; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar. Electronic address: sdermime@hamad.qa.

Publikováno v: European journal of pharmacology [Eur J Pharmacol] 2023 Apr 15; Vol. 945, pp. 175612. Date of Electronic Publication: 2023 Feb 22.

DNA methylation of immune checkpoints in the peripheral blood of breast and colorectal cancer patients.

Autor: Elashi AA; Cancer Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar., Sasidharan Nair V; Cancer Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar., Taha RZ; Cancer Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar., Shaath H; Cancer Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar., Elkord E; Cancer Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.; Institute of Cancer Sciences, University of Manchester, Manchester, UK.

Publikováno v: Oncoimmunology [Oncoimmunology] 2018 Nov 10; Vol. 8 (2), pp. e1542918. Date of Electronic Publication: 2018 Nov 10 (Print Publication: 2019).